Form 8-K - Current report:
SEC Accession No. 0001628280-25-037596
Filing Date
2025-08-05
Accepted
2025-08-05 07:05:15
Documents
16
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mdgl-20250805.htm   iXBRL 8-K 28306
2 EX-99.1 a2q25pressrelease_final.htm EX-99.1 46924
6 image_0a.jpg GRAPHIC 364388
7 image_1a.jpg GRAPHIC 61955
8 mdgllogo.jpg GRAPHIC 4562
  Complete submission text file 0001628280-25-037596.txt   796427

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20250805.xsd EX-101.SCH 1803
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdgl-20250805_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20250805_pre.xml EX-101.PRE 13060
18 EXTRACTED XBRL INSTANCE DOCUMENT mdgl-20250805_htm.xml XML 2858
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 251182753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)